Qingdao Life Diary International Trade Co., Ltd. – Trademark Portfolio
Entity Type: 99
Qingdao Life Diary International Trade Co., Ltd. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 26 (Fancy Goods) — 5 filings in this category. Currently, 5 trademarks are registered. Notable registered marks include KOINU, AGRAMIS, FLORAZE, MUSPLUTO, and SIRENSWAN. The owner is based in Shandong.
No. 375, Mingshiyuan, Zhongyun Street
Office, Jiaozhou City, Qingdao City,
Shandong 266300 , CN
Showing of trademarks Trademarks
Trademark Classifications
Qingdao Life Diary International Trade Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Lace and embroidery, ribbons and braid; buttons, hooks and eyes, pins and needles
Frequently Asked Questions
How many trademarks does Qingdao Life Diary International Trade Co., Ltd. have?
Qingdao Life Diary International Trade Co., Ltd. has 5 U.S. trademarks filed with the USPTO. Of these, 5 registered.
What trademark classes does Qingdao Life Diary International Trade Co., Ltd. file in?
Qingdao Life Diary International Trade Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 26 (Fancy Goods). Class 26 covers lace and embroidery, ribbons and braid; buttons, hooks and eyes, pins and needles.
What are Qingdao Life Diary International Trade Co., Ltd.'s most well-known trademarks?
Qingdao Life Diary International Trade Co., Ltd.'s registered trademark portfolio includes well-known marks such as KOINU, AGRAMIS, FLORAZE, MUSPLUTO, and SIRENSWAN. These are among 5 currently registered trademarks in the portfolio.
What is Qingdao Life Diary International Trade Co., Ltd.'s trademark registration success rate?
Qingdao Life Diary International Trade Co., Ltd. has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.